Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection

Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and b...

Full description

Saved in:
Bibliographic Details
Published inBMC psychiatry Vol. 18; no. 1; pp. 239 - 6
Main Authors Hamdani, Nora, Bengoufa, Djaouida, Godin, Ophélia, Doukhan, Raphaël, Le Guen, Emmanuel, Daban-Huard, Claire, Bennabi, Meriem, Delavest, Marine, Lépine, Jean-Pierre, Boukouaci, Wahid, Laouamri, Hakim, Houenou, Josselin, Jamain, Stéphane, Richard, Jean-Romain, Lecorvosier, Philippe, Yolken, Robert, Rajagopal, Krishnamoorthy, Leboyer, Marion, Tamouza, Ryad
Format Journal Article
LanguageEnglish
Published London BioMed Central 27.07.2018
BioMed Central Ltd
BMC
Subjects
Bipolar disorder
Comparative analysis
Complications and side effects
Cytomegalovirus
Genetic aspects
Health aspects
Human health and pathology
Humoral immunity
Immunoglobulins
Immunological diseases
Life Sciences
Medicine
Medicine & Public Health
Mental disorders
Physiological aspects
Psychiatrics and mental health
Psychiatry
Psychotherapy
Psychotic disorders
Research Article
Risk factors
Schizophrenia
Toxoplasma gondii
Toxoplasmosis
France
Schizophrenia
Bipolar disorder
Immunoglobulins
Humoral immunity
Toxoplasma gondii
Online AccessGet full text
ISSN1471-244X
1471-244X
DOI10.1186/s12888-018-1821-9

Cover

Abstract Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. Methods 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Results Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Conclusions Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
AbstractList Abstract Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. Methods 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Results Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Conclusions Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. Methods 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Results Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Conclusions Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection.BACKGROUNDImmune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection.334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ.METHODS334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ.Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls.RESULTSAlthough lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls.Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.CONCLUSIONSSchizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection. Methods 334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ. Results Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls. Conclusions Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders. Keywords: Humoral immunity, Immunoglobulins, Bipolar disorder, Schizophrenia, Toxoplasma gondii
BACKGROUND:Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying pro-inflammatory state. Studies on humoral immune responses (which reflects antibody mediated fight against pathogens) in schizophrenia and bipolar disorder are sparse and often providing contradictory results. The aim of this study was to assess humoral immunity in a group of stable bipolar disorder and schizophrenia patients compared to controls by determining total Immunoglobulins and IgG subclasses and to assess their association with latent Toxoplasma gondii and/or CMV infection.METHODS:334 subjects (124 BD, 75 SZ and 135 Healthy Controls [HC]) were included and tested for humoral immunity by determining the total immunoglobulins (IgG,A and M) and IgG subclasses (IgG1, IgG2, IgG3, IgG4) and their relationship with latent Toxoplasma gondii infection, an established risk factor for BD and SZ.RESULTS:Although lower levels of IgG, IgG1, IgG2, IgG4 and IgA were found among BD as compared to HC and/or SZ, after adjustment for confounding variables, only low levels of IgG and IgG1 in BD remai- ned significant. Strikingly highest levels of antibodies to T. gondii (but not CMV) infection in BD and SZ were associated with lowest levels of IgG3 and IgG4 levels as compared to controls.CONCLUSIONS:Schizophrenia and bipolar disorder patients with latent T. gondii specific infection may be more vulnerable to changes in immuno-inflammatory processes than controls with similar latent infectious state. Simultaneous sequential immunological monitoring both in steady state and active disease phases in the same BD and SZ patients are warranted to understand the role of Toxoplasma gondii latency in these disorders.
ArticleNumber 239
Audience Academic
Author Godin, Ophélia
Houenou, Josselin
Rajagopal, Krishnamoorthy
Hamdani, Nora
Le Guen, Emmanuel
Laouamri, Hakim
Jamain, Stéphane
Richard, Jean-Romain
Lépine, Jean-Pierre
Lecorvosier, Philippe
Daban-Huard, Claire
Bengoufa, Djaouida
Boukouaci, Wahid
Delavest, Marine
Yolken, Robert
Leboyer, Marion
Tamouza, Ryad
Doukhan, Raphaël
Bennabi, Meriem
Author_xml – sequence: 1
  givenname: Nora
  surname: Hamdani
  fullname: Hamdani, Nora
  email: nora.hamdani@aphp.fr
  organization: Inserm U955, Team 15 «Genetic Psychiatry », AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry, Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 2
  givenname: Djaouida
  surname: Bengoufa
  fullname: Bengoufa, Djaouida
  organization: Jean Dausset Laboratory, LabEx Transplantex & INSERM, UMRS 1160 Saint Louis Hospital, Paris Diderot University
– sequence: 3
  givenname: Ophélia
  surname: Godin
  fullname: Godin, Ophélia
  organization: Inserm U955, Team 15 «Genetic Psychiatry », Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 4
  givenname: Raphaël
  surname: Doukhan
  fullname: Doukhan, Raphaël
  organization: AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry
– sequence: 5
  givenname: Emmanuel
  surname: Le Guen
  fullname: Le Guen, Emmanuel
  organization: Inserm U955, Team 15 «Genetic Psychiatry », AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry
– sequence: 6
  givenname: Claire
  surname: Daban-Huard
  fullname: Daban-Huard, Claire
  organization: Inserm U955, Team 15 «Genetic Psychiatry », AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry, Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 7
  givenname: Meriem
  surname: Bennabi
  fullname: Bennabi, Meriem
  organization: Jean Dausset Laboratory, LabEx Transplantex & INSERM, UMRS 1160 Saint Louis Hospital, Paris Diderot University
– sequence: 8
  givenname: Marine
  surname: Delavest
  fullname: Delavest, Marine
  organization: AP-HP, Paris Diderot University, Psychiatry, Lariboisiere Fernand Widal Hospital
– sequence: 9
  givenname: Jean-Pierre
  surname: Lépine
  fullname: Lépine, Jean-Pierre
  organization: AP-HP, Paris Diderot University, Psychiatry, Lariboisiere Fernand Widal Hospital
– sequence: 10
  givenname: Wahid
  surname: Boukouaci
  fullname: Boukouaci, Wahid
  organization: Jean Dausset Laboratory, LabEx Transplantex & INSERM, UMRS 1160 Saint Louis Hospital, Paris Diderot University
– sequence: 11
  givenname: Hakim
  surname: Laouamri
  fullname: Laouamri, Hakim
  organization: Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 12
  givenname: Josselin
  surname: Houenou
  fullname: Houenou, Josselin
  organization: Inserm U955, Team 15 «Genetic Psychiatry », AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry, Fondation Fondamental, Scientific Cooperation Foundation, CEA Saclay, Neurospin
– sequence: 13
  givenname: Stéphane
  surname: Jamain
  fullname: Jamain, Stéphane
  organization: Inserm U955, Team 15 «Genetic Psychiatry », Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 14
  givenname: Jean-Romain
  surname: Richard
  fullname: Richard, Jean-Romain
  organization: Inserm U955, Team 15 «Genetic Psychiatry », Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 15
  givenname: Philippe
  surname: Lecorvosier
  fullname: Lecorvosier, Philippe
  organization: CIC 006Henri Mondor INSERM & Biological Resource Platform, Paris Est University, AP-HP
– sequence: 16
  givenname: Robert
  surname: Yolken
  fullname: Yolken, Robert
  organization: Stanley Laboratory of Developmental Neurovirology, Johns Hopkins University Medical Center
– sequence: 17
  givenname: Krishnamoorthy
  surname: Rajagopal
  fullname: Rajagopal, Krishnamoorthy
  organization: Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 18
  givenname: Marion
  surname: Leboyer
  fullname: Leboyer, Marion
  organization: Inserm U955, Team 15 «Genetic Psychiatry », AP-HP, DHU Pe-PSY, Paris Est Créteil University, Henri Mondor - Albert Chenevier, Group, psyChiatry, Fondation Fondamental, Scientific Cooperation Foundation
– sequence: 19
  givenname: Ryad
  surname: Tamouza
  fullname: Tamouza, Ryad
  organization: Fondation Fondamental, Scientific Cooperation Foundation, Jean Dausset Laboratory, LabEx Transplantex & INSERM, UMRS 1160 Saint Louis Hospital, Paris Diderot University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30053866$$D View this record in MEDLINE/PubMed
https://inserm.hal.science/inserm-01857935$$DView record in HAL
BookMark eNp9UsuO1DAQjNAi9gEfwAVF4sKBLHbsOA4HpNEKdkcaicsicbNsx5nxKLGDnSyPX-Cn6UxmYWcEKIck3VXVdnWdJyfOO5MkzzG6xJizNxHnnPMMYZ5hnuOsepScYVriLKf088mD79PkPMYtQrjkBX6SnBKECsIZO0t-LrtudH7dejW21qVxVJluZYxpbeMQrBoH610KHWV738ow1X2oTUilq9OoN_aH7zfBOCvfpr0fjBusbNNgWjkx48b26Vc7bFL4h15667_5HgZ0Mr32rrYWtBujJ-zT5HEj22ie7d8XyacP72-vbrLVx-vl1WKVaUbRkGEluWyMVERiWSFOCdKKVCyvOKOqlqxQeaERLzFqZEmKklY1aRRBORB1hchFspx1ay-3og-2k-G78NKKXcGHtZBhsLo1QtcU5VwzhhChWholG0p53uT5NLghoPVu1upH1ZlawxWDbA9EDzvObsTa3wmG4MC0BIHXs8DmiHazWAnrogmdgAUXZUWKOwzwV_t5wX8ZTRxEZ6M2bSud8WMUOYIVVyVhHKAvj6BbPwYHzgKKT2bRnRl71FrCfWEXHo6pJ1GxKApW4ZJxBqjLv6DgqU1nNaSysVA_ILx46Mvvm90nDwDlDNDBxxhMI7QddpEBZdsKjMSUcTFnfLJATBkXFTDxEfNe_H-cfOZEwLq1CX-8-DfpF0dGD7o
CitedBy_id crossref_primary_10_1016_j_jpsychires_2021_07_041
crossref_primary_10_1186_s12888_020_02540_0
crossref_primary_10_1016_j_pnpbp_2024_110993
crossref_primary_10_1038_s41537_021_00143_6
crossref_primary_10_3389_fpsyt_2019_00766
crossref_primary_10_1016_j_jpsychires_2022_07_013
crossref_primary_10_1038_s41380_023_02183_z
crossref_primary_10_3390_biomedicines12050998
crossref_primary_10_1038_s41598_022_16420_y
crossref_primary_10_1590_1516_4446_2020_0904
crossref_primary_10_3389_fpsyt_2023_1102450
crossref_primary_10_1155_2021_6634807
crossref_primary_10_1186_s12888_023_04820_x
crossref_primary_10_1186_s12888_024_05979_7
crossref_primary_10_3389_fimmu_2019_00418
crossref_primary_10_1016_S0140_6736_20_31544_0
Cites_doi 10.1016/j.biopsych.2011.04.013
10.1016/j.biopsych.2003.10.008
10.1371/journal.pntd.0006040
10.1016/j.jad.2012.11.034
10.1093/schbul/13.2.261
10.1192/bjp.134.4.382
10.1093/schbul/sbm005
10.1007/BF03033242
10.1016/j.schres.2010.06.010
10.1016/j.biopsych.2007.09.022
10.1111/j.1600-0447.1977.tb03560.x
10.1001/archpsyc.1973.01750350053010
10.1016/j.psc.2015.09.006
10.1016/0920-9964(93)90077-V
10.1111/acps.12423
10.1007/BF00380962
10.4306/pi.2016.13.1.18
10.1128/CMR.8.1.131
10.1001/archpsyc.60.5.466
10.1002/rcm.7753
10.3389/fpsyt.2011.00063
10.1002/hup.390
10.1016/S0033-3182(80)73619-8
10.1001/archpsyc.1994.03950110009002
10.1192/bjp.133.5.429
10.1159/000117771
10.1111/j.1360-0443.1991.tb01879.x
10.1176/appi.ajp.2007.06081254
10.3389/fnins.2015.00372
10.1192/bjp.132.4.342
ContentType Journal Article
Copyright The Author(s). 2018
COPYRIGHT 2018 BioMed Central Ltd.
Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s). 2018
– notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID C6C
AAYXX
CITATION
NPM
3V.
7TK
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
1XC
VOOES
5PM
DOA
DOI 10.1186/s12888-018-1821-9
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList


PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-244X
EndPage 6
ExternalDocumentID oai_doaj_org_article_cd4028c660034caebaf4482f229084f3
PMC6062947
oai_HAL_inserm_01857935v1
A556917686
30053866
10_1186_s12888_018_1821_9
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AZQEC
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DWQXO
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IPY
ITC
KQ8
M1P
M2M
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c640t-1ba8afeab3a1a908430cb39629864bda65b25c08710fa735749d3fb302ba8c903
IEDL.DBID M48
ISSN 1471-244X
IngestDate Wed Aug 27 01:23:03 EDT 2025
Thu Aug 21 18:20:29 EDT 2025
Fri May 09 12:28:16 EDT 2025
Fri Sep 05 13:21:20 EDT 2025
Fri Jul 25 21:55:45 EDT 2025
Tue Jun 17 21:35:17 EDT 2025
Tue Jun 10 20:34:17 EDT 2025
Wed Feb 19 02:36:18 EST 2025
Tue Jul 01 00:25:58 EDT 2025
Thu Apr 24 23:12:30 EDT 2025
Sat Sep 06 07:21:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Schizophrenia
Bipolar disorder
Immunoglobulins
Humoral immunity
Toxoplasma gondii
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c640t-1ba8afeab3a1a908430cb39629864bda65b25c08710fa735749d3fb302ba8c903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC6062947
ORCID 0000-0001-5004-5475
0000-0003-0402-9591
0000-0001-5473-3697
0000-0003-3992-9565
0000-0002-4321-4100
0000-0003-3166-5606
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12888-018-1821-9
PMID 30053866
PQID 2089864490
PQPubID 44775
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_cd4028c660034caebaf4482f229084f3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6062947
hal_primary_oai_HAL_inserm_01857935v1
proquest_miscellaneous_2078597368
proquest_journals_2089864490
gale_infotracmisc_A556917686
gale_infotracacademiconefile_A556917686
pubmed_primary_30053866
crossref_citationtrail_10_1186_s12888_018_1821_9
crossref_primary_10_1186_s12888_018_1821_9
springer_journals_10_1186_s12888_018_1821_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-07-27
PublicationDateYYYYMMDD 2018-07-27
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-27
  day: 27
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC psychiatry
PublicationTitleAbbrev BMC Psychiatry
PublicationTitleAlternate BMC Psychiatry
PublicationYear 2018
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References A Amkraut (1821_CR1) 1973; 28
N Hamdani (1821_CR12) 2013; 148
E Pulkkinen (1821_CR27) 1977; 56
JM Gowdy (1821_CR10) 1980; 21
1821_CR37
AS Brown (1821_CR5) 2011; 2
SR Kay (1821_CR14) 1987; 13
JD Rosenblat (1821_CR28) 2016; 39
1821_CR31
W Chong-Thim (1821_CR6) 1993; 10
SL Buka (1821_CR4) 2008; 63
EF Toorey (1821_CR33) 1978; 132
C Bălăiţă (1821_CR3) 1992; 30
B Tudorache (1821_CR34) 1991; 29
SG Tiwari (1821_CR32) 1984; 26
JI Nurnberger (1821_CR25) 1994; 51
L-H Lo (1821_CR16) 2016; 30
BJ Miller (1821_CR17) 2011; 70
NIMH (1821_CR24) 1992
FB Dickerson (1821_CR7) 2003; 60
S Legros (1821_CR15) 1985; 235
N Muller (1821_CR20) 2006; 10
DW Niebuhr (1821_CR23) 2008; 165
TF Heatherton (1821_CR13) 1991; 86
AA Wadee (1821_CR35) 2002; 17
1821_CR2
1821_CR21
F Dickerson (1821_CR9) 2007; 33
A Muneer (1821_CR22) 2016; 13
JI Nurnberger Jr (1821_CR26) 1994; 5
AS Sane (1821_CR29) 1990; 32
S Corp (1821_CR30) 2013
RC Young (1821_CR38) 1978; 133
PB Mortensen (1821_CR19) 2010; 122
A Fontana (1821_CR11) 1980; 6
SA Montgomery (1821_CR18) 1979; 134
RH Yolken (1821_CR36) 1995; 8
FB Dickerson (1821_CR8) 2004; 55
References_xml – volume: 70
  start-page: 663
  issue: 7
  year: 2011
  ident: 1821_CR17
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2011.04.013
– volume: 55
  start-page: 588
  issue: 6
  year: 2004
  ident: 1821_CR8
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2003.10.008
– ident: 1821_CR37
  doi: 10.1371/journal.pntd.0006040
– volume: 148
  start-page: 444
  issue: 2–3
  year: 2013
  ident: 1821_CR12
  publication-title: J Affect Disord
  doi: 10.1016/j.jad.2012.11.034
– volume: 13
  start-page: 261
  issue: 2
  year: 1987
  ident: 1821_CR14
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/13.2.261
– volume: 134
  start-page: 382
  issue: 4
  year: 1979
  ident: 1821_CR18
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.134.4.382
– volume: 33
  start-page: 737
  issue: 3
  year: 2007
  ident: 1821_CR9
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbm005
– volume: 10
  start-page: 131
  issue: 2
  year: 2006
  ident: 1821_CR20
  publication-title: Neurotox Res
  doi: 10.1007/BF03033242
– volume: 122
  start-page: 257
  issue: 1–3
  year: 2010
  ident: 1821_CR19
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2010.06.010
– volume: 63
  start-page: 809
  issue: 8
  year: 2008
  ident: 1821_CR4
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.09.022
– volume: 56
  start-page: 173
  issue: 3
  year: 1977
  ident: 1821_CR27
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/j.1600-0447.1977.tb03560.x
– volume: 32
  start-page: 88
  issue: 2
  year: 1990
  ident: 1821_CR29
  publication-title: Panminerva Med
– volume: 28
  start-page: 673
  issue: 5
  year: 1973
  ident: 1821_CR1
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1973.01750350053010
– volume: 30
  start-page: 63
  issue: 1
  year: 1992
  ident: 1821_CR3
  publication-title: Rom J Neurol Psychiatry
– volume: 39
  start-page: 125
  issue: 1
  year: 2016
  ident: 1821_CR28
  publication-title: Psychiatr Clin North Am
  doi: 10.1016/j.psc.2015.09.006
– volume: 10
  start-page: 61
  issue: 1
  year: 1993
  ident: 1821_CR6
  publication-title: Schizophr Res
  doi: 10.1016/0920-9964(93)90077-V
– ident: 1821_CR31
  doi: 10.1111/acps.12423
– volume: 235
  start-page: 9
  issue: 1
  year: 1985
  ident: 1821_CR15
  publication-title: Eur Arch Psychiatry Neurol Sci
  doi: 10.1007/BF00380962
– volume: 13
  start-page: 18
  issue: 1
  year: 2016
  ident: 1821_CR22
  publication-title: Psychiatry Investig
  doi: 10.4306/pi.2016.13.1.18
– ident: 1821_CR2
– volume: 8
  start-page: 131
  issue: 1
  year: 1995
  ident: 1821_CR36
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.8.1.131
– volume-title: Genetics initiative: family interview for genetic studies (FIGS)
  year: 1992
  ident: 1821_CR24
– volume: 60
  start-page: 466
  issue: 5
  year: 2003
  ident: 1821_CR7
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.60.5.466
– volume: 30
  start-page: 2645
  year: 2016
  ident: 1821_CR16
  publication-title: Rapid Commun Mass Spectrom
  doi: 10.1002/rcm.7753
– volume: 2
  start-page: 63
  year: 2011
  ident: 1821_CR5
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2011.00063
– volume: 29
  start-page: 35
  issue: 1–2
  year: 1991
  ident: 1821_CR34
  publication-title: Rom J Neurol Psychiatry
– volume: 17
  start-page: 175
  issue: 4
  year: 2002
  ident: 1821_CR35
  publication-title: Hum Psychopharmacol
  doi: 10.1002/hup.390
– volume-title: Stats statistical software: release 13
  year: 2013
  ident: 1821_CR30
– volume: 21
  start-page: 751
  issue: 9
  year: 1980
  ident: 1821_CR10
  publication-title: Psychosomatics
  doi: 10.1016/S0033-3182(80)73619-8
– volume: 51
  start-page: 849
  year: 1994
  ident: 1821_CR25
  publication-title: Archives General Psychiatry
  doi: 10.1001/archpsyc.1994.03950110009002
– volume: 26
  start-page: 223
  issue: 3
  year: 1984
  ident: 1821_CR32
  publication-title: Indian J Psychiatry
– volume: 133
  start-page: 429
  issue: 5
  year: 1978
  ident: 1821_CR38
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.133.5.429
– volume: 6
  start-page: 284
  issue: 5
  year: 1980
  ident: 1821_CR11
  publication-title: Neuropsychobiology
  doi: 10.1159/000117771
– volume: 86
  start-page: 1119
  issue: 9
  year: 1991
  ident: 1821_CR13
  publication-title: Br J Addict
  doi: 10.1111/j.1360-0443.1991.tb01879.x
– volume: 165
  start-page: 99
  issue: 1
  year: 2008
  ident: 1821_CR23
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2007.06081254
– volume: 5
  start-page: 849
  year: 1994
  ident: 1821_CR26
  publication-title: Arch General Psychiatr
  doi: 10.1001/archpsyc.1994.03950110009002
– ident: 1821_CR21
  doi: 10.3389/fnins.2015.00372
– volume: 132
  start-page: 342
  year: 1978
  ident: 1821_CR33
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.132.4.342
SSID ssj0017851
Score 2.2999732
Snippet Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying...
Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying...
Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying...
BACKGROUND:Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an underlying...
Abstract Background Immune dysfunction could play a significant role in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ), conditions with an...
SourceID doaj
pubmedcentral
hal
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 239
SubjectTerms Bipolar disorder
Comparative analysis
Complications and side effects
Cytomegalovirus
Genetic aspects
Health aspects
Human health and pathology
Humoral immunity
Immunoglobulins
Immunological diseases
Life Sciences
Medicine
Medicine & Public Health
Mental disorders
Physiological aspects
Psychiatrics and mental health
Psychiatry
Psychotherapy
Psychotic disorders
Research Article
Risk factors
Schizophrenia
Toxoplasma gondii
Toxoplasmosis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QF8SZQkJFASKCojl-JuS2IsiDKqZV6s2zH0UZqk6i7i_gP_Glm8lgaKuDCMfEknnhmHE_85RtCXnBYJosca4T5qFPptUqdwMAzPCifyVhFTBSPvurlifx8qk4vlfpCTNhADzwM3EEoIcMpgtbIpBJc9K6CjIJXyFNeyKrn-WSGTcnUuH-AJefHPcys0AdrmIULBG1BxlQgJmH2FurJ-ndT8vUVIiKvLjevoiZ_2zrt30iHt8mtcSlJF8Mj3CHXYnOX3DgaN8vvkR-f8N-PFik_EG5O11ufBlws0xLZcsdCVxRafN1hhovneypO6pqSri_D8d7Srt0gsAg6vJjwc6u6o_gdl8IxtNHj9nvbQQfnjn5sm7Ku6QT1au6Tk8MPx--X6Vh7IQ1ask2aeVe4KjovXOZwpAULXhjNkc7dl04rz1VgkG6xyuVC5dKUovJgZrgwGCYekL2mbeIjQo2LQpamyjlKce28jCqaAIlUUFHHhLDJFjaMxORYH-PM9glKoe1gPgvms2g-axLyendJN7By_E34HRp4J4iE2v0JcDM7upn9l5sl5BW6h8WwB-WCG_9egEdEAi27UEpD5qsLnZD9mSSEa5g1vwQHmymzXHwBaZhxzlFrBTOm-pbBbSYXtOO0srYQWTj-0rCEPN81Yw8IlWtiu0UZcH6TC10k5OHgsbvesDaBKDQokc98eabOvKWpVz3pOCS63Mg8IW8mr_-l1h-H_vH_GPon5CbHyGV5yvN9sre52MansBLc-Gd90P8E9-NaRA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokRAXxJuUgowEQgJFZONHbC5oQZQFUU6ttDfLdhx2JZqk-0D8B_40M1knJVT0uPFkPck84i-efEPI8xyWyazAHmEuyJQ7KVLLMPB07oWb8FAFBIrH3-TslH-Zi3l84baOZZV9TuwSddl4fEcOIF0hkzjX2bv2PMWuUbi7Glto7JHrHXUZ-HMxHwBX13g-7mROlHyzhlyssHQLcJPCyoTRs6ij7B8S894C6yIvLzov107-s4HaPZeObpNbcUFJpzsPuEOuhfouuXEct8zvkd-f8QuQBok_sOicrrcu9bhkpiVy5sZ2VxRG3LJFnIvHO0JOauuSrv8uyntL22aD5UUw4aqvolssW4pvcyn8hjF60vxqWpjgzNJPTV0ul7Qv-Krvk9OjjycfZmnswJB6ybNNOnFW2SpYx-zE6kxxlnnHtMzRFK60Urhc-AxAV1bZgomC65JVDowNJ3qdsQdkv27q8IhQbQPjpa6KHKVyaR0PImgPcMqLIENCst4Wxkd6cuyS8cN0MEVJszOfAfMZNJ_RCXk1nNLuuDmuEn6PBh4EkVa7O9CsvpsYpcaXAKeVlxJpe7wNzlYAX_MKSfEVr1hCXqJ7GAx-UM7b-A0DXCLSaJmpEBLwr1QyIYcjSQhaPxp-AQ42UmY2_QrSkHfOUGsBeVP8nMDf9C5oYnJZm4tQSMizYRhnwIK5OjRblAHn1wWTKiEPdx47zIYdCpiSoEQx8uWROuORernoqMcB7uaaFwl53Xv9hVr_vfUHV1_EY3Izx5jMijQvDsn-ZrUNT2Clt3FPu3D-AwHnUjI
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDI_YkBAviG8KAwUJhASqaPPVhLdjYhyI8bRJe4uSNNVV2tpqd4f2P-yfxu71ysoAicc2TuOr7dQ-Oz8T8oqBm8wL7BHmo0qFVzJ1HA3PsCB9LmIVMVA8_K7mx-LriTwZwKLxLMzV_H2u1fsl7J8ay60g1tFYTbBDbsqcqz4vq_bHhAH2mB-Sln-cNvns9Oj84x68s8ASyOv-5fUyyd9ypf0n6OAuuTP4jnS2EfY9ciM298mtwyE7_oBcfsHDHi1ifGB9OV2ufRrQO6YlwuMOna0ojPi6w5AW7_fYm9Q1JV1erb_7QLt2hZVEsOD5tmBuUXcU_7ilcA1j9Ki9aDtY4MzRz21T1jXd1nY1D8nxwaej_Xk6NFtIgxLZKs29066KznOXO5NpwbPguVEM8dt96ZT0TIYM4quscgWXhTAlrzzIFSYGk_FHZLdpm_iEUOMiF6WpCoZUTDkvoowmQOQUZFQxIdlWFjYMSOTYEOPU9hGJVnYjPgvisyg-axLydpzSbWA4_kX8EQU8EiKCdn8DFMsOBmlDCZGzDkohQk9w0bsKIlVWIf69FhVPyBtUD4t2DswFNxxXgJ-IiFl2JqWCUFdplZC9CSXYZ5gMvwYFmzAzn30DathizpBrCVuk_JHDY7YqaId9ZGnBlPD9C5Ml5OU4jCtgbVwT2zXSgPKbgiudkMcbjR1Xw2YEXCtgopjo8oSd6UhTL3qUcYhsmRFFQt5ttf4XW3999U__i_oZuc3QRLMiZcUe2V2dr-Nz8PFW_kVv3T8BN8tKsg
  priority: 102
  providerName: Springer Nature
Title Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection
URI https://link.springer.com/article/10.1186/s12888-018-1821-9
https://www.ncbi.nlm.nih.gov/pubmed/30053866
https://www.proquest.com/docview/2089864490
https://www.proquest.com/docview/2078597368
https://inserm.hal.science/inserm-01857935
https://pubmed.ncbi.nlm.nih.gov/PMC6062947
https://doaj.org/article/cd4028c660034caebaf4482f229084f3
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbWTZr2BfFOYFRGAiGBAmnsODESQm21URCd0LRKFV8s23FopS0pfUHjN_CnuUuTlrDBB75USnyuHfvOvie-PEfI0xDcZBZjjjDjhM-NiHzN0PBkaCPT4S5zCBSHJ2Iw4h_H0XiH1OmtqgFcXAvtMJ_UaH7-6vLbj3dg8G9Lg0_E6wWssQmGZAEeSjDioEX2YGMSiMWGfHuogHnoq4PNa6sdkH0kb2dJSZm43aVKMv_Nkt2aYMTkVXf0alTlH0er5Y51fJPcqFxN2l3rxi2y4_LbZH9YHabfIT8_4LchBVKCYDg6XayMb9GZpimy6VaJsCiUmOkMhwnvl1SdVOcpXfwerveGzoolBh5Bg_M6vm4ynVF8z0vhGsroWXFZzKCBC03fF3k6ndI6FCy_S0bHR2f9gV_lZvCt4MHS7xid6Mxpw3RHyyDhLLCGSREi3btJtYhMGNkA4FiQ6ZhFMZcpywyoAVS0MmD3yG5e5O4BoVI7xlOZxSFKhUIb7iInLQAtGznhPBLUc6FsRVyO-TPOVQlgEqHWM6lgJhXOpJIeebGpMluzdvxLuIcTvBFEwu3yRjH_qir7VTYFoJ1YIZDQx2pndAbANsyQLj_hGfPIc1QPhYoKnbO6-roBHhEJtlQ3igQgY5EIjxw2JMGcbaP4GShYozOD7ieQhhXpAnsdwYoafe_A39QqqGqrUWB5OP5cBh55sinGFjCULnfFCmXADmTMROKR-2uN3bRWq79H4oYuN7rTLMmnk5KUHIBwKHnskZe11m-79dehf_jf7TwiByFabhD7YXxIdpfzlXsM7uHStEkrHsdtstc7Ovl8Cld90W-Xr1ra5XIAv6e9L78A0Ldn4g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELa2TgK-IN4JDDASExIoInViJ0ZCqIONlrUVQpu0b8Z2HFqJJaEvvPwG_gu_kbs06QgT-7aPjS_2uXc-3xOf7wh5wsBNDmOsEWac8CMjuK9DXHiSWW66kcscAsXRWPSPovfH_HiD_G7uwmBYZWMTK0OdFha_kQNITzCTeCSD1-VXH6tG4elqU0JjpRYH7ud3gGzzV4O3IN8dxvb3Dt_0_bqqgG9FFCz8rtGJzpw2oe5qGSRRGFgTSsGwe5NqwQ3jNgAgEWQ6DnkcyTTMDEwAXrQyCKHfTbIV4Y3WDtna3Rt_-Lg-t8BS9_XZaTcRL-Zg_RMMFgOklmAsRGv3q4oErLeCzQlGYp51c89Ga_5zZFvthPvXyNXahaW9lc5dJxsuv0EujepD-pvk1wDvnBSYagTD3Ol8aXyLTjpNMUtvXWCLQouZlois8XmVApTqPKXzv8MAX9KyWGBAEww4a-L2JtOS4vdjCr-hjR4WP4oSBjjR9F2Rp9MpbULM8lvk6EKkc5t08iJ3dwmV2oVRKrOYIRUT2kSOO2kBwFnuhPNI0MhC2TohOtbl-KIqYJQItRKfAvEpFJ-SHnm2fqVcZQM5j3gXBbwmxETe1YNi9lnVdkHZFAB8YoXAREFWO6MzAMwswzT8SZSFHnmK6qHQ3ABzVte3JmCKmLhL9TgXgLhFIjyy3aIEM2FbzTugYC1m-r0hUIOlO0GuOVhq_q0L3TQqqGpzNleni88jj9fNOAKG6OWuWCINKL-MQ5F45M5KY9ejYU2EMBHARNzS5RY77ZZ8OqmSnQPAZjKKPfK80fpTtv771987fxKPyOX-4WiohoPxwX1yheH6DGKfxduks5gt3QPwMxfmYb24Kfl00fbkDz7hkBk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZokSouiDeBAkYCIYGiZuNHbG5LoWyhrTi0Um-W7TjsSjSJ9oH4D_xpZvKCUEDimHgcz3pmbM_O-BtCnqVwTGYZ1ghzQcbcSRFbhoanUy_chIcioKN4fCJnZ_zDuTjv6pyu-mz3PiTZ3mlAlKZyvVfnRWviSu6tYFVVmIQFHpDCHIMtcpXjzofRWrk_hBGw8nwXyvxjt9Fm1GD2Dyvz1hwTIy-fOi8nT_4WQW02poMb5Hp3oqTTVgVukiuhvEV2jruY-W3y_RCvgFSI_IFZ53S1cbHHMzPNETS3q3dFocUtanR08X2DyEltmdPVr1l5r2ld4TSB0tJln0Y3X9QU_86l8Axt9LT6VtUwwIWl76syXyxon_FV3iFnB-9O92dxV4Ih9pIn63jirLJFsI7ZidWJ4izxjmmZIqq7y60ULhU-Aa8rKWzGRMZ1zgoH0oaOXifsLtkuqzLcJ1TbwHiuiyxFqlRax4MI2oM_5UWQISJJLwvjO3xyLJPxxTR-ipKmFZ8B8RkUn9EReTl0qVtwjn8Rv0EBD4SIq928qJafTWemxufgTysvJeL2eBucLcB_TQtExVe8YBF5geph0PqBOW-7SwzwExFHy0yFkOAASyUjsjuiBKv1o-bnoGAjZmbTI6CGhecCuRawcIqvE_hMr4KmW11WBgwM55_rJCJPh2YcATPmylBtkAaUX2dMqojcazV2GA1LFDAlgYlspMsjdsYt5WLeYI-Dv5tqnkXkVa_1P9n669Q_-C_qJ2Tn09sDc3R48vEhuZaitSZZnGa7ZHu93IRHcAhcu8eNof8Ana5V5g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunoglobulin+sub-class+distribution+in+bipolar+disorder+and+schizophrenia%3A+potential+relationship+with+latent+Toxoplasma+Gondii+infection&rft.jtitle=BMC+psychiatry&rft.au=Hamdani%2C+Nora&rft.au=Bengoufa%2C+Djaouida&rft.au=Godin%2C+Oph%C3%A9lia&rft.au=Doukhan%2C+Rapha%C3%ABl&rft.date=2018-07-27&rft.pub=BioMed+Central&rft.eissn=1471-244X&rft.volume=18&rft_id=info:doi/10.1186%2Fs12888-018-1821-9&rft_id=info%3Apmid%2F30053866&rft.externalDocID=PMC6062947
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-244X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-244X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-244X&client=summon